AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT01124812 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 131I-L19SIP Radioimmunotherapy (RIT) in Combination With External Beam Radiotherapy (EBRT) and Concurrent Chemotherapy
Description: Lung tumor irradiation with a total dosage of between 60-66 Gy, fractionated in combination with the following concurrent chemotherapy options:~1. Cohorts 1, 2 \& 3a is composed of cisplatin i.v. 80 mg/m2 on day 1, and vinorelbine i.v. 25 mg/m2 on day 1, 8, 15 for cycle 1 \& 4. For patients with significant comorbidities, the dose of vinorelbine is reduced to 12.5 mg/m2 during cycles 2 \& 3. Treatment cycles will be repeated every 28 days.~2. Protocol A (suggested for patients with comorbidities: Carboplatin 70 mg/m2, over 30 min iv, (Day 1-5 ) + Vinorelbine 12.5 mg/m2 as a 5-min bolus iv or short iv-infusion (Day 1, 8, 22), repeated on Day 28.~3. Protocol B (suggested for patients in good clinical condition): Paclitaxel 50 mg/m2 1 hour iv (Day 1, 15, 22, 29, 36, 43, 50) + Carboplatin AUC 2, 30 min iv on (Day 1, 15, 22, 29, 36, 43, 50).~   * Total treatment duration is 8-16 weeks
Study NCT04158219 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral activation for health and depression (BA-HD)
Description: Consistent with successful BA manuals, we plan to conduct up to 10 sessions of treatment over 12 weeks (the recommendation will be at least 8 sessions; scheduling of sessions will be flexible and conform to patient preference). The initial two sessions will be about 50 minutes long and later sessions will be 20-30 minutes long. Sessions can be done on site or over the phone; home visits will be offered for sessions 1-2 if a participant cannot travel. Treatment sessions will use behavioral activation techniques to assess participant values and link these values to behavior change. Goal-setting will focus on sequential, idiographic behavior change (tobacco use, medication adherence, physical activity, and diet) and be accompanied by educational materials and commercially available tools (e.g. activity trackers, pillboxes).
Study NCT03828955 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Soybean peptides
Description: Subjects receive two bags soybean peptides per day for 8 weeks of a stage. Anthropometric measurements such as blood pressure (systolic blood pressure \[SBP\] and diastolic blood pressure \[DBP\]), body weight, body fat, waistline, hipline and blood biochemical parameters including FBG, albumin, TC, TG, HDL-C, LDL-C, Cr, BUN, AST and ALT were measured every four weeks.
Study NCT03828955 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Subjects receive two bags of starch placebo of similar appearance per day for 8 weeks of a stage. Anthropometric measurements such as blood pressure (systolic blood pressure \[SBP\] and diastolic blood pressure \[DBP\]), body weight, body fat, waistline, hipline, and blood biochemical parameters including FBG, albumin, TC, TG, HDL-C, LDL-C, Cr, BUN, AST, and ALT were measured every four weeks.
Study NCT03972215 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Berberine Chloride
Description: Traditional Chinese Medicine
Study NCT03972215 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Berberine Chloride
Description: Traditional Chinese Medicine
Study NCT03972215 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo Control
Study NCT03972215 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo Control
Study NCT04401332 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: mobile health app
Description: asthma symptom monitoring via a clinically integrated mobile health (mHealth) app installed on patients' smartphones
Study NCT04743622 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Monoprost
Description: preservative-free latanoprost 1 drop once a day for 12 weeks to target eyes
Study NCT04743622 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Xalatan
Description: preserved latanoprost 1 drop once a day for 12 weeks to target eyes
Study NCT02405598 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Salbutamol
Description: 1. Albuterol Syrup (1mL= Salbutamol 0.4mg, 60ml/bot)~2. VENTOLIN TABLETS 2MG (SALBUTAMOL SULPHATE)
Study NCT02635893 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: D-Cycloserine
Description: 100 mg of Seromycin by mouth will be administered
Study NCT02635893 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: placebo pill will be administered instead of medication by mouth
Study NCT02635893 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Training
Description: walking around a designated track at different speeds both forward and backward
Study NCT02635893 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Stimulation
Description: magnetic stimulation and electrical stimulation may be applied
Study NCT01265186 — intervention group
Intervention type: DEVICE
Intervention: Bispectral Index
Description: The Bispectral-Index is continuously recorded for up to 72 hours in the group of ventilated newborns. Every 15 minutes, a value that was generated by averaging the BIS values of the last 15 minutes will be recorded (automatically calculated by the software of the readout device). The Bispectral-Index is continuously recorded for a minimum of 4 hours in the controls.
Study NCT02635893 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Placebo Stimulation
Description: this is a fake stimulation that is administered but will be unknow to the subject.
Study NCT03193983 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Flaps Coverage
Description: Surgical group will undergo surgical coverage of the fingertip defect by V-Y flap using the skin on the volar aspect of the same finger designed as V shaped then mobilized dorsally to cover the defect and stitches to be Y shaped. Stitches are removed after 2 weeks.
Study NCT03193983 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Occlusive Dressing
Description: Conservative group will undergo minimal trimming of the bone end and an occlusive dressing that is changed on a weekly basis till complete healing of the defect that occurs after 6 weeks.
Study NCT02144103 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Subtenon administration of autologous ADRC
Study NCT02144103 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Liposuction
Study NCT02144103 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ADRC isolation
Description: ADRC isolation performed using Celution 800/CRS System (Cytori Therapeutics Inc) according to manufacturer's protocol
Study NCT02090010 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Seldinger technique
Description: The aimed vessel(subclavian vein) is punctured with a sharp hollow needle, syringe is detached and guidewire is advanced through the lumen of the needle, and the needle is removed.~After that catheter is passed over the guidewire into the vessel.
Study NCT02090010 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Modified Seldinger technique
Description: The aimed vessel is punctured with the needle that is covered with guiding sheath. After vessel is punctured, guiding sheath is instantly slid over the needle into the vessel. The needle is removed, guidewire is advanced through the sheath, central catheter is placed into the vessel.
Study NCT00223847 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Constraint Induced Language Therapy
Study NCT01265186 — intervention group
Intervention type: DEVICE
Intervention: Amplitude-integrated EEG
Description: A aEEG is recorded once daily for a minimum of four hours in the group of ventilated newborns. In Controls an aEEG is recorded once for a minimum of four hours.
Study NCT04301895 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Continuous conversational interaction
Description: Maintaining continuous conversation, requiring that the subject answer questions and engage in discussion without interruption.
Study NCT04277780 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring Sensor
Description: Placement of continuous glucose monitor sensor for 14 days. Instructions on how to peel off the sensor and mail it back to the clinician.
Study NCT04277780 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Diabetes Management Instructions
Description: Instructions on checking fingerstick blood glucose and information on the required equipment including glucose test strips, lancets, and glucometer. Instructions on how to log blood glucose values onto the blood glucose log sheet for 14 days, and how to mail it back to the clinician.
Study NCT04277780 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Diabetes Management Instructions
Description: Instructions on checking fingerstick blood glucose and information on the required equipment including glucose test strips, lancets, and glucometer. Instructions on how to log blood glucose values onto the blood glucose log sheet for 14 days, and how to mail it back to the clinician.
Study NCT01219712 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Colloids, dobutamin, levosimendan
Description: : The main aim of goal-directed therapy is to achieve a normal oxygen delivery to the tissues i.e. DO2 500-600ml/min/m2.~* Hb would be optimized to > 90 g/l~* SaO2 > 96%~* Stroke volume index (SVI) > 30~* Heart rate should ideally be \< 80~Stroke volume index (SVI) > 30 is achieved by repeated volume substitution in the form of 100-200 ml colloid. If, despite bolus doses of colloids, the SVI is \< 30, one would have to use ionotropic drugs e.g. dobutamine or levosimendan, in order to achieve this goal
Study NCT01219712 — intervention group
Intervention type: PROCEDURE
Group type: NO_INTERVENTION
Intervention: Colloids, dobutamin, levosimendan
Description: : The main aim of goal-directed therapy is to achieve a normal oxygen delivery to the tissues i.e. DO2 500-600ml/min/m2.~* Hb would be optimized to > 90 g/l~* SaO2 > 96%~* Stroke volume index (SVI) > 30~* Heart rate should ideally be \< 80~Stroke volume index (SVI) > 30 is achieved by repeated volume substitution in the form of 100-200 ml colloid. If, despite bolus doses of colloids, the SVI is \< 30, one would have to use ionotropic drugs e.g. dobutamine or levosimendan, in order to achieve this goal
Study NCT02149407 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Glycerin
Description: Glycerin group GG will receive the 0.5 suppository (700 mg) twice daily for 48 hours. We will use the rounded part and discard the other part then will hold baby's buttocks for 2 minutes to ensure its delivery.
Study NCT02149407 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Rectal stimulation
Description: Rectal stimulation SG by soft cotton swab inserted to around 3 cm. The stick will press against the rectal wall in all direction for 2 minutes twice daily for 48 hours. Ky gel will be used to lubricate the stick and minimize direct friction to rectal wall.
Study NCT02149407 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Control
Description: Control group CG will receive routine NICU medical care without any specific intervention for the infant. The research nurse will do shame placebo twice daily by opening his diaper to blind the team for 2 minutes.
Study NCT03603197 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BP-C1
Description: BP-C1, 0.05% solution for injection; doses: 0.035 mg/kg body weight (0.07 mL/kg) intramuscularly once daily for 32 consecutive days
Study NCT03603197 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo, solution for injection; doses: 0.07 mL/kg body weight intramuscularly once daily for 32 consecutive days
Study NCT04206345 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: exercise with blood flow restriction
Description: Elbow bending exercises with blood flow restriction will be performed to the exercise group.
Study NCT04206345 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: exercise
Description: Elbow bending exercises
Study NCT05178823 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chlorhexidine mouthwash
Description: Comparison of oral rinses
Study NCT05178823 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Chlorhexidine mouthwash
Description: Comparison of oral rinses
Study NCT01834170 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine
Description: Two intratumoral injections of gemcitabine under endoscopic ultrasound (EUS)-guidance at month 0 and month 3.~The patients will receive systemic chemotherapy with or without radiotherapy at the discretion of oncologist
Study NCT02876796 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GS-0976
Description: Capsule(s) administered orally
Study NCT02876796 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Capsule(s) administered orally
Study NCT02876796 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 1-13C acetate
Description: 10 g ± 0.25 g in 1000 mL 0.45% saline solution administered intravenously for 19 hours
Study NCT04301895 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Remifentanil infusion
Description: 10 minute remifentanil infusion
Study NCT03247868 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Botulinum Toxin+SPRInt
Description: Botulinum toxin injections in association with rehabilitative approach to cervical dystonia (SPRInt)
Study NCT03447301 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Extra virgin olive oil (30mL daily)
Description: Intervention arm will take 30 mL of Extra virgin olive oil daily.
Study NCT00033618 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ixabepilone
Description: Given IV
Study NCT00033618 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: laboratory biomarker analysis
Description: Correlative studies
Study NCT02876796 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fructose solution
Description: Fructose solution administered orally under fasted conditions immediately after study drug and every 30 minutes for a total of 20 doses
Study NCT02083796 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Shoulder impingement_TSM
Description: A physiotherapist with 4 years of experience in manual therapy will administer the TSM targeting the middle thoracic spine of the subjects.
Study NCT02083796 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Asymptomatic_TSM
Description: A physiotherapist with 4 years of experience in manual therapy administered the TSM targeting the middle thoracic spine of the subjects.
Study NCT02083796 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Shoulder impingement_sham
Description: A physiotherapist with 4 years of experience in manual therapy administered the sham intervention targeting the middle thoracic spine of the subjects.
Study NCT02083796 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Asymptomatic_sham
Description: A physiotherapist with 4 years of experience in manual therapy administered the sham intervention targeting the middle thoracic spine of the subjects.
Study NCT03361605 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Propofol
Description: Propofol administration
Study NCT02713477 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Insulin glargine/ lixisenatide fixed-ratio combination HOE901/AVE0010
Description: Pharmaceutical form: solution~Route of administration: subcutaneous
Study NCT02713477 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Insulin glargine HOE901
Description: Pharmaceutical form: solution~Route of administration: subcutaneous
Study NCT02343367 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: behavioral counseling
Description: Pediatrician trained in motivational interviewing techniques provides brief lifestyle behavioral counseling to child and parent using a Healthy Lifestyle Prescription
Study NCT02343367 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: behavioral counseling
Description: Pediatrician trained in motivational interviewing techniques provides brief lifestyle behavioral counseling to child and parent using a Healthy Lifestyle Prescription
Study NCT02713477 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Pharmaceutical form: solution~Route of administration: subcutaneous
Study NCT04457349 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Therapeutic Plasma Exchange (TPE)
Description: Treatment with Therapeutic Plasma Exchange (TPE)
Study NCT02866032 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MOB015B
Study NCT02866032 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ciclopirox 80 mg/g
Study NCT01453127 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: I-123 Ioflupane solution injection prior to SPECT scan (DaTscan)
Description: I-123 Ioflupane solution for injection into a living test subject. The iodine introduced during manufacture is a radioactive isotope, I-123, and it is the properties of this isotope that makes the solution visible to a gamma camera on SPECT imaging. I-123 has a half-life of approximately 13 hours and a gamma photon energy of 159 keV making it an good radionuclide for medical imaging. DaTscan is administered by intravenous cannula. The scan is carried out 3-6 hours post injection.
Study NCT01453127 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Single photon emission computed tomography (SPECT) scan
Description: Single-photon emission computed tomography(SPECT)is a nuclear medicine tomographic imaging technique using gamma rays. It is very similar to conventional nuclear medicine planar imaging using a gamma camera. However, it is able to provide true 3D information. This information is typically presented as cross-sectional slices through the patient, but can be freely reformatted or manipulated as required.
Study NCT02343367 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Education Materials
Description: Health education materials about healthy eating and physical activity and a community resource guide
Study NCT02343367 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Education Materials
Description: Health education materials about healthy eating and physical activity and a community resource guide
Study NCT02343367 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Face to face counseling session
Description: 30 minute face-to-face family-centered behavioral counseling session delivered by a health educator
Study NCT02343367 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Text messages
Description: regularly scheduled cell phone text messages for 12 months
Study NCT02343367 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Text messages
Description: regularly scheduled cell phone text messages for 12 months
Study NCT02343367 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Telephone Counseling
Description: 14 telephone counseling sessions delivered by a health educator using motivational interviewing techniques. Two sessions per month for the first two months followed by one session per month for 10 months
Study NCT02343367 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Newsletters
Description: 12 monthly newsletters mailed to participant homes
Study NCT02653365 — intervention group
Intervention type: DEVICE
Intervention: Non-invasive ventilation
Description: Noninvasive ventilation (NIV) was performed with a noninvasive ventilator (BiPAP Synchrony®, Respironics Inc., Murrysville, PA, USA).
Study NCT03333759 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Alma - Harmony XL Laser
Description: The Erbium YAG laser at a 2940nm wavelength is used for ablative laser resurfacing as well as treating acne scars.
Study NCT02164903 — intervention group
Intervention type: OTHER
Intervention: QoL Survey Booklet
Study NCT02899351 — intervention group
Intervention type: DEVICE
Intervention: Respiratory Volume Monitor
Study NCT00582413 — intervention group
Intervention type: BEHAVIORAL
Intervention: questionnaires
Description: Patient will fill out questionnaires, initial clinic visit, first post-surgery clinic evaluation and 3, 6, 12, 18 and 24 months following completion of all therapy.
Study NCT03156192 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Survey
Description: Survey on the level of depression, quality of life, current and past music experiences, and perceived benefits of music in relation to psycho-social needs
Study NCT01940432 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: electroacupuncture group
Description: Procedure: electro-acupuncture;Points: Bilateral Zhong Liao (BL33) Hui Yang(BL35).Specially-made pad is stick on pierced acupoints. Bilateral BL33 are given acupuncture of 50一60mm with 30一45°angle to inward and downward by 75mm filiform needle. Bilateral BL35 are given acupuncture of 50一60mm to outward and upward by 75mm filiform needle. Twirl, lift and thrust for 3 times, until local sour and heavy feeling coming.The electric stimulator is applied to bilateral BL33 and BL35, with dilatational wave,50 Hz and electric current 1一5mA(milliampere).Every session lasts for 30 min per day.The participants are treated continuously for 8 weeks for 3 sessions a week, 24 sessions for each patient in all. The treatment is designed based on recent literature research in 10 years, former result and expert consensus.